NCT03388476

Brief Summary

Measurement of the endtidal carbon dioxide by capnography to exclude or to ensure the diagnosis pulmonary hypertension. The aim of the study is to obtain an endtidal carbon dioxide cut-off value for the diagnostic algorithm for pulmonary hypertension as an easily measurable and cheap diagnostic tool in patients with suspicion of pulmonary hypertension.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
105mo left

Started May 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress48%
May 2018Jan 2035

First Submitted

Initial submission to the registry

December 22, 2017

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 3, 2018

Completed
4 months until next milestone

Study Start

First participant enrolled

May 2, 2018

Completed
11.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2030

Expected
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2035

Last Updated

May 19, 2022

Status Verified

May 1, 2022

Enrollment Period

11.7 years

First QC Date

December 22, 2017

Last Update Submit

May 18, 2022

Conditions

Keywords

pulmonary hypertensionendtidal co2endtidal carbon dioxidepulmonary arterial hypertension

Outcome Measures

Primary Outcomes (1)

  • Measurement PetCO2

    Measurement PetCO2 by capnography at rest after or before a right heart catheterization, comparison of the parameter between patients with and without

    At baseline

Secondary Outcomes (1)

  • Establishing a cut-off

    At baseline

Study Arms (1)

Suspicion of pulmonary hypertension

At Patients with suspicion of pulmonary hypertension, which get a right heart catheterization, in the context of the study the exhaled air, precious the endtidal carbon dioxide (CO2), before or after the right heart catheterization will be measured through capnography.

Diagnostic Test: Capnography

Interventions

CapnographyDIAGNOSTIC_TEST

Measuring of the exhaled air, especially endtidal co2, through capnography.

Suspicion of pulmonary hypertension

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients of a tertiary referral center retro- and prospective part of the study. Afterwards in a next prospective study part patients in ambulant setting.

You may qualify if:

  • Age \> 18 years, suspicion of pulmonary hypertension, planned or accomplished right heart catheterization

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Clinic Giessen and Marburg

Giessen, Hesse, 35392, Germany

Location

Related Publications (1)

  • Hemnes AR, Pugh ME, Newman AL, Robbins IM, Tolle J, Austin ED, Newman JH. End tidal CO(2) tension: pulmonary arterial hypertension vs pulmonary venous hypertension and response to treatment. Chest. 2011 Nov;140(5):1267-1273. doi: 10.1378/chest.11-0155. Epub 2011 May 26.

    PMID: 21622547BACKGROUND

MeSH Terms

Conditions

Hypertension, PulmonaryFamilial Primary Pulmonary HypertensionVascular DiseasesLung DiseasesPulmonary Arterial Hypertension

Interventions

Capnography

Condition Hierarchy (Ancestors)

Respiratory Tract DiseasesHypertensionCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Respiratory Function TestsDiagnostic Techniques, Respiratory SystemDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Henning Gall, MD, PhD

    University Clinic Giessen and Marburg - Campus Giessen

    PRINCIPAL INVESTIGATOR
  • Werner Seeger, Prof.

    University Clinic Giessen and Marburg

    STUDY DIRECTOR
  • Ardeschir Ghofrani, Prof.

    University Clinic Giessen and Marburg

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Study Chair: Ghofrani H. Ardeschir, Prof. Dr. University of Giessen

Study Record Dates

First Submitted

December 22, 2017

First Posted

January 3, 2018

Study Start

May 2, 2018

Primary Completion (Estimated)

January 1, 2030

Study Completion (Estimated)

January 1, 2035

Last Updated

May 19, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations